Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Virashiv Tablet
Manufacturer/Marketed By : SHIVNAAM TRADELINK LLP
$38.33 $12.48
Virashiv tablet is an Anti-Viral drug belonging to the non-nucleoside and nucleoside reverse transcriptase inhibitors containing the active ingredients Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate. It is used in the treatment...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
EFAVIRENZ,EMTRICITABINE,TENOFOVIR DISOPROXIL FUMARATE
Active Pharmaceutical Ingredient
Virashiv Tablet
38.33$
12.48$
Virashiv tablet is an Anti-Viral drug belonging to the non-nucleoside and nucleoside reverse transcriptase inhibitors containing the active ingredients Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate. It is used in the treatment of HIV-1 infection. It is a Human immunodeficiency virus that mainly occurs when a person's immune system is attacked and weakened by the human immunodeficiency virus (HIV). This infection progressively weakens the immune system, making individuals more susceptible to opportunistic infections. This tablet is not recommended if you have experienced hypersensitivity reactions to Efavirenz, Emtricitabine, or Tenofovir disoproxil fumarate. Patients diagnosed with pancreatitis or at risk of pancreatitis should take this combination of medicine cautiously. During the treatment, your doctor may periodically monitor your blood counts, bone mineral density, and liver and kidney parameters to prevent serious complications. Report to your doctor if you have had a history of heart failure, seizures, pancreatitis, bone disease, fractures, mental illnesses, or liver or kidney problems. Seek medical emergency from a nearby hospital if you experience psychiatric symptoms like depression or suicidal thoughts during this treatment. Adults of childbearing potential should consider using an effective contraceptive to prevent unwanted pregnancy. Avoid getting pregnant during and 12 weeks after the last dose of the Virashiv tablet. If you are pregnant or think you might be pregnant, your physician might suggest an alternative treatment, as this combination regimen is not recommended during early pregnancy. Breastfeeding is mostly not recommended due to the potential transmission of HIV from the mother to the baby.
Active Pharmaceutical Ingredient
Uses
• Treatment of HIV-1 infection
Benefits
Virashiv tablets increase the number of CD4 T cells and stimulate the immune system to fight against infections. Thereby, it reduces the viral load of HIV in the blood and decreases the severity of HIV infection.
Side Effects
Side Effects are unwanted symptoms caused by medicines. Although all medicines cause side effects, not everyone gets them.
Most Common Side Effects
• Diarrhea
• Headache
• Sleeplessness
• Increased levels of cholesterol and glucose in the blood
• Breast enlargement in males
• Anemia
• Bone disorders
• Tinnitus
• Constipation
Common Side Effects
• Rapid breathing
• Drowsiness
• Nausea, vomiting, and stomach pain
• Severe allergic reactions
• Severe mood disturbances, depression, and suicidal thoughts
• Confusion, forgetfulness, seizures, and tremor
• Liver toxicity
• Kidney damage
How To Use
Take the Virashiv tablet as advised by your physician. Swallow the tablets whole and intact. This tablet should be taken with food. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition. Only stop taking the medicine if your doctor advises you to stop.
Safety Advice
• Breast Feeding: Breastfeeding is not recommended in patients taking Virashiv tablet because the medicine gets into the breast milk and affects your fetus. Do not breastfeed during the treatment.
• Alcohol: It is highly unsafe to drink alcohol while taking a Virashiv tablet. It may reduce the drug's effectiveness and can cause toxic side effects.
• Liver: Inform your physician about any underlying liver disorders before taking this Virashiv tablet, and it should be used with caution in liver disease patients. Your doctor may monitor your liver enzymes. Consult your physician before taking this medicine.
• Lungs: It is unknown whether Virashiv tablets are safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.
• Driving: Virashiv tablet can make you feel dizzy and affect your concentration. Do not drive or operate machinery.
• Pregnancy: If pregnant, do not take the Virashiv tablet because this may harm the unborn baby.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.